Investigational Site Number :0400001

Linz 4020

0 studies enrolling now · 2 studies all time

What they study most

Chronic Graft Versus Host Disease, Non-relapsing Secondary Progressive Multiple Sclerosis

Studies at this site

• A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. — Running, not enrolling
• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed